The activities of Bitter leaf (Vernonia amygdalina) 
I. Introduction
Vernonia amydalina commonly called "Bitter leaf" is a medium sized shrub with petiolate green leaf of about 6mm diameter and elliptic in shape. This leaves have found relevance in traditional folk medicine as anti helmintics, anti malaria, anti microbial, anti cancer and as a laxative herb. This study is designed to evaluate the activity of this herbaceous plant on haemostatic mechanism and biochemical profile of induced diabetic male albino rats. The genus vernonia is named by English botanist William Vernon. Several species of vernonia including V.calvoana, V.amygdalina, and V.colorata are eaten as leaf vegetables (Akah and Okafor1992). Common names for these species include onugbu(Igbo), Ndole (cameroun), Ewuro(Yoruba), Shawaka(Hausa) Oguntola 2013. They are common in most west African and central African countries. The leaves have a sweet and bitter taste and are solid, fresh or dry, and are a typical ingredient in melon(Egusi)soup. The leave can be eaten like spinach in soup or dried too. Diabetes mellitus (DM) is a common disorder associated with increased morbidity and mortality and can be regarded as a group of metabolic diseases characterized by chronic hyperglycemia due to effective insulin secretion , insulin action or both resulting impaired carbohydrate, lipid, protein metabolism. The use of vernonia amygdalina in the treatment of diabetes mellitus is very common among ethno medical practitioners, hence this research is also aimed at authenticating the use of this herb in treating diabetes by herbalist. Fluids from fresh leaves are pressed out and applied to bleeding cuts and wound and will stop the bleeding of minor wounds (Oguntola, 2013), thus exhibiting a haemostatic property.
Other medicinal value of bitter leaf:
Regular consumption of vegetables such as Vernonia amygdalina (Bitter leaf) and Telfaria occidentalis (Ugu) can help to regulate blood cholesterol level, a risk factor for heart attack and stroke. This build up of cholesterol and other substances called plaque, can narrow the artery like a clogged drain, leading to arteriosclerosis, or hardening of the arteries over time, this causes heart attack (Oguntola, 2013). The 2011 study published in African Journal of Biochemical Research showed that the treatment with bitter leaf and ugu diets led to a significant increase in serum good cholesterol (HDL-C) showing their protective role in condition that affects the heart and blood vessels such as heart attack.
Also common skin diseases such as ringworm, eczema and others have been successfully treated with bitter leaf because of its antimicrobial effect. In many communities, individuals squeeze and paste bitter leaf regularly on the affected portion of the skin, coupled with the drinking of the fresh bitter leaf juice. This clears the skin diseases in short time.
II. Materials and methods: Animals:
Twenty one (21) male albino rats were randomly selected. They were kept in animal house for 14 days to get acclimatized to the environment before commencing an acute feeding which lasted for 30 days. The rats were housed in a wire mesh cage under standard conditions (Temperature 25-30 o c, 12hr light and 12hr darkness cycle). They were allowed free access to water and feed produced by Pfizer, Nigeria limited Benin Edo state), throughout the period of the experiment. Generally, the study was conducted in accordance with the recommendation from the declarations of Helsink on guiding principles in care and use by animals.
Plants materials:
Fresh leaves of V. amygdalina were obtained freshly from a farm in Umuoma Uli, and the leaves were identified by a taxonomist being used for the research study.
Experimental design:
Twenty-one (21) male albino rats weighing 130-150g were placed into three groups namely Group 1 (control) Group 2 (induced diabetic rat on bitter leaf extract) and Group 3 (induced diabetic rats on dianil tablets). The test rats were fed on normal rat pellet and water ad libitum in addition to oral administration of 5mg/ml once daily of the aqueous leaf extract of V. amygdalina.
PREPARATION OF EXTRACT OF VERNONIA AMYGDALINA:
Fresh leaves of V. amygdalina were collected, washed very well to remove saponins to concentrations that are okay for the body to handle; they were weighed, cut and left to dry in hot air oven. The crude extraction method by Ugochukwu et al 2003, and Edet et al (2009) was used for the preparation of the extract. The leaves were further dried in sunlight for 18 days. The dried sample was crushed to powder using a mechanical blender. The powdered leaves were stored in a glass bottle with a plastic screw cap and kept in a refrigerator (4 o c). The leaves were homogenized with distilled water by shaking and kept for 12 hours. The mixtures were filtered with Whatman No. 1 Filter paper. The filtrates were concentrated to one tenth (1/10) of the original volumes at 38-40 o c using a rotary evaporator. The aqueous extract was freeze dried yielding a brown powder. The powders were resuspended in distilled water to make a concentration of 5mg/ml before use. The extract was administered to the rats using a 5ml syringe with blunt needle.
PHYTOCHEMICAL ANALYSIS OF THE LEAVES:
The aqueous extract of the leaves was screened for the presence or absence of various secondary metabolites using standard phytochemical screening procedures as described by Harbourne (1973) and Trease and Evans (1996). The extract was tested for resins, calcium, alkaloids, flavenoids, reducing sugars, saponins, glycosides, carbohydrates, steroids, acidic compounds, fats and oils.
TOXICITY STUDIES:
The LD 50 of extracts in albino rats was determined using Lorke's method (1983) . The procedure of determining the lethal dose is by increasing the concentration of the extracts administered to the rats (per body weight) in each group consisting of eight (8) rats per group for five (5) days. The concentration used are 500mg/kg, 100mg/kg, 2000mg/kg, 3000mg/kg, 4000mg/kg, 5000mg/kg, 6000mg/kg, and 7000mg/kg respectively. The mortality rate was determined and a graph plotted to determine the LD 50 .
INDUCTION OF DIABETES (HPERGLYCERMIA) IN RATS:
Hyperglycemia (diabetes) was induced in male wister albino rats by intraperitoneal administration of alloxan monohydrates (150mg/kg body weight) dissolved in normal saline given at the rate of 0.4ml at 48 hours intervals. The rats were fasted for 18 hours before the first injection. The alloxan is capable of producing fatal hypoglycemia as a result of massive pancreatic in insulin release, rats were treated with 30% glucose solution orally at different time intervals after 6 hours of alloxan induction of 5% glucose solution was kept in bottles in their cages for the next 24 hours to prevent hypoglycemia.
After 7 days, the rats with diabetes mellitus glycosuria (indicated by urinalysis and blood glucose estimation), and hyperglycermia with glucose range of 300-350mg/dl were used for the tests. Induction of diabetes was accomplished by three doses of alloxan that was administered at third injection, the rats were fasted again and the blood glucose level was recorded.
ORAL ADMINISTRATION OF THE AQUEOUS EXTRACT:
After the induction of diabetes in the rats, all the induced rats with their blood sugar levels from the range of 300-350mg/dl were subjected to feeding with the aqueous extract of bitter leaf for 28 days. The level of the needle (i.e. the sharp edge was cut off to make it blunt). The volume forced into the mouth of the animal is 2.0ml of the extract. They were allowed access to their normal rat feed and drinking water ad libitum.
COLLECTION OF SAMPLES FOR TESTS:
At the end the acute feeding (28 days) of the extracts, cardiac puncture was used to collect 2.0ml of blood samples from the diabetic rats and control rats into EDTA bottles for tests. Their weight, full count blood count including platelet count, bleeding time, clotting time and prothrombin time were measured.
DETERMINATION OF HAEMOSTATIC AND BIOCHEMICAL PROFILE:
Blood samples collected into EDTA sequestrene bottles were used for the haematological studies within hours of sample collection while those collected in sodium citrate bottle were spun and the plasma extracted for the determination of haemostatic profile. The packed cell volume was determined according to the haematocrit method described by Alexander and Griffiths 1993, while the white blood cell count and platelet count were determined according to the visual method of Dacie and Lewis (1991). The whole blood clotting time and the bleeding time were carried out by the method of Dejana et al, 1982. The prothrombin time test was carried out by the method of Quick's one stage method as described in Baker (1985) . The levels of blood sugar was determined using B.G meter.
STATISTICAL ANALYSIS:
The data obtained from the study were expressed as mean and standard deviation (Mean ± S.D) while student's t test was used to compare the result of the control and the test. A P-value of less than or equivalent to (p<0.05) or (p=0.05) was regarded as statistically significant.
III.
Results: 
IV. Discussions
The activities of Bitter leaf (Vernonia amygdalina) extract on haemostatic and biochemical profile of induced male diabetic albino rats have been evaluated. Most times, plant extracts are given to humans in excessive doses by the ethnomedical practitioners. Toxicity may affect the result of the study and so acute toxicity studies using LD 50 were carried out before the extract was administered to the animals. The result of lethality studies showed that the LD 50 in rats using Bitter leaf extract was 5000mg/kg (Fig 1) . The volume (1ml) containing 5mg/kg concentration of the extract was far below the lethal dose and so was considered safe to the animal used throughout the period of study.
The activities of Bitter leaf extracts on haemostatic and biochemical profile provides physiological information on a blood assessment in the body (Ita et al, 2007) . It is clearly shown in Table 2 that the extracts of V. amgdalina has no effect on haemoglobin concentration, packed cell volume, white blood cells and platelet count (p>0.05).
The result from the biochemical study showed that the tested aqueous leaf extract of Vernonia amygalina induced significant reductions in the blood glucose concentrations of normoglycaemic and alloxaninduced diabetic rats. The findings of this investigation may therefore suggest that the plant extract could at least in part, stimulate insulin production and glucose utilization, like chlopropamide to bring its hypoglycaemic effect in the mammalian experimental animals used. Although the present findings suggest the presence of hypoglyceamic compounds in leaf extract of Vernonia amygdalina, the precise mechanism of its hypoglycaemic action is still speculative and requires further studies for appropriation elucidation. It is however interesting to note that the plant extract, like chloropropanide is as effective in reducing the blood glucose concentrations of diabetic rats as in reducing the blood glucose concentration of normoglycaemic rats.
Bitter leaf does not only reduce the blood sugar level drastically, it also helps to repair the pancreas (Ogundotola, 2013). According to a study published in the Journal of Pharmacy and Bioresources researchers at the University of Jos, Nigeria stated that the crude chloroform extract of the leaves of Bitter leaf has an antidiabetic effect in rats with diabetes mellitus (Type 2 Diabetes) under labouratory conduction.
The extract demonstrated haemostatic activity by shortening bleeding time, bleeding time and prothrombin time. Oguntola 2013 pointed out that the leaves of V. amygdalina if squeezed and placed on cuts would stop bleeding of injured vessels. It is rich in calcium, vitamin C and saponins. It was observed that calcium was a principal active ingredients present in plasma and bones. It is free calcium ions that are physiologically active in coagulation mechanism. Calcium ions are essential for the conversion of prothrombin to thrombin and for the normal action of heart muscle and for neuromuscular conduction.
